Related Experiment Videos
Internal quality control of PCR-based genotyping methods: practical experiences
Else-Marie Bladbjerg1, Jørgen Gram, Jørgen Jespersen
1Department for Thrombosis Research, University of Southern Denmark, Department of Clinical Biochemistry, Ribe County Hospital, Esbjerg, Denmark. emb@ribeamt.dk
Vascular Pharmacology
|March 6, 2003
Summary
Implementing internal quality control for genetic testing is crucial. This study proposes a quality control program for polymerase chain reaction (PCR)-based analyses of hemostasis polymorphisms, ensuring reliable thrombosis research.
Area of Science:
- Molecular Biology
- Genetics
- Clinical Chemistry
Background:
- Internal quality control (IQC) programs are essential for the accuracy and reliability of genetic analyses.
- Thrombosis research relies on precise genetic polymorphism data, necessitating robust quality control measures.
- Current genetic analysis workflows require systematic evaluation of pre-analytical, analytical, and post-analytical factors.
Purpose of the Study:
- To evaluate quality control aspects of selected polymorphism analyses used in thrombosis research.
- To assess the effectiveness of different stages in the analytical procedure, including sample handling, DNA isolation, amplification, digestion, electrophoresis, and data management.
- To propose a comprehensive internal quality control program for polymerase chain reaction (PCR)-based hemostasis polymorphism analyses.
Main Methods:
- DNA was isolated from 500 EDTA-blood samples and analyzed for 18 polymorphisms using PCR-based techniques (RFLP, allele-specific amplification, insertion/deletion amplification).
- Evaluation encompassed pre-analytical (sample handling, DNA isolation), analytical (amplification, enzyme digestion, electrophoresis), and post-analytical (result reading, database entry) factors.
- A procedure for result confirmation and data handling error assessment was implemented.
Main Results:
- Isolated DNA quality was consistently high (42 µg/ml, A260/A280 ratio > 1.75).
- Reanalysis was occasionally required due to positive reagent blanks (<1%) or control issues (<5%).
- Genotyping discrepancies were identified in 4 instances upon confirmation, with minor data handling errors (0.1% reading, 0.5% entry).
Conclusions:
- The study highlights the importance of rigorous internal quality control in genetic testing for thrombosis research.
- A proposed IQC program addresses key aspects of PCR-based hemostasis polymorphism analysis, from sample handling to data entry.
- Implementing such a program can enhance the accuracy and reproducibility of genetic analyses in clinical and research settings.